13F HOLDINGS REPORT (Amended)
VR Adviser, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001104659-23-060784
Total Value
$648.1M
Positions
31
Other Managers
0
Confidential Omitted
No
Holdings (31)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Tricida Inc | 89610F101 | 9,050,064 | $94.8M | 14.63% |
| 2 | Aclaris Therapeutics Inc | ACRS | 4,563,962 | $71.8M | 11.08% |
| 3 | Cogent Biosciences Inc | COGT | 4,038,117 | $60.2M | 9.30% |
| 4 | Relmada Therapeutics Inc | RLMD | 1,518,056 | $56.2M | 8.67% |
| 5 | Viridian Therapeutics Inc | VRDN | 2,130,308 | $43.7M | 6.74% |
| 6 | GH Research PLC | GHRS | 3,333,154 | $38.7M | 5.98% |
| 7 | Pliant Therapeutics Inc | PLRX | 1,080,000 | $22.6M | 3.48% |
| 8 | Milestone Pharmaceuticals Inc | MIST | 2,425,737 | $22.3M | 3.44% |
| 9 | Terns Pharmaceuticals Inc | TERN | 3,707,891 | $21.8M | 3.37% |
| 10 | Marinus Pharmaceuticals Inc | 56854Q200 | 3,156,803 | $21.0M | 3.24% |
| 11 | Gossamer Bio Inc | GOSS | 1,747,000 | $20.9M | 3.23% |
| 12 | Annexon Inc | ANNX | 3,220,050 | $19.9M | 3.07% |
| 13 | Instil Bio Inc | TIL | 4,105,779 | $19.9M | 3.07% |
| 14 | Akouos Inc | 00973J101 | 2,800,566 | $18.9M | 2.92% |
| 15 | Dice Therapeutics Inc | 23345J104 | 764,979 | $15.5M | 2.39% |
| 16 | Aerovate Therapeutics Inc | 008064107 | 833,927 | $13.8M | 2.13% |
| 17 | LianBio | LIANY | 5,378,341 | $10.8M | 1.66% |
| 18 | Fulcrum Therapeutics Inc | FULC | 1,200,000 | $9.7M | 1.50% |
| 19 | Inozyme Pharma Inc | 45790W108 | 2,709,987 | $7.3M | 1.12% |
| 20 | Ventyx Biosciences Inc | 92332V107 | 207,925 | $7.3M | 1.12% |
| 21 | Prometheus Biosciences Inc | 74349U108 | 121,663 | $7.2M | 1.11% |
| 22 | Savara Inc | SVRA | 4,555,038 | $7.1M | 1.09% |
| 23 | Provention Bio Inc | 74374N102 | 1,118,653 | $5.0M | 0.78% |
| 24 | Altimmune Inc | ALT | 369,306 | $4.7M | 0.73% |
| 25 | Trevi Therapeutics Inc | TRVI | 3,050,022 | $4.7M | 0.72% |
| 26 | Lyra Therapeutics Inc | LYRA | 924,170 | $4.6M | 0.71% |
| 27 | Immunocore Holdings PLC | IMCR | 94,605 | $4.4M | 0.69% |
| 28 | aTyr Pharma Inc | ATYR | 1,398,889 | $4.2M | 0.65% |
| 29 | Rallybio Corp | RLYB | 268,532 | $3.9M | 0.60% |
| 30 | Affimed NV | N01045108 | 1,428,571 | $2.9M | 0.45% |
| 31 | Celldex Therapeutics Inc | CLDX | 75,000 | $2.1M | 0.33% |